The Emmes Group Newsroom features updates on the work we’re doing to advance clinical research and public health. Here you’ll find news about partnerships, contract awards, technology innovations, leadership appointments, industry recognition, and expert perspectives. It’s where we share how Emmes, Veridix, and our global teams are shaping the future of clinical research.

We know that successful partnerships begin at the very first interaction with you and are fostered by an undivided focus on your needs.

We look forward to talking with you, learning more about your specific goals and determining how we can help you.

Who We Are

At Emmes Group, our work is driven by a simple but profound belief: truth matters. Since our founding in 1977, we’ve been committed to uncovering truth in clinical research - through scientific rigor, operational excellence, and deep collaboration with our clients and partners.

At Emmes Group, numbers tell a story of lasting impact. For nearly five decades, we’ve supported the world’s most complex clinical trials with scientific rigor, global reach, and cutting-edge technology. Our key metrics reflect not only the scale of our operations, but also the trust placed in us by leading sponsors, government agencies, and researchers around the world. These numbers are more than stats—they represent our commitment to uncovering the truth behind medical innovation.

The Veridix Biostats and Analysis Agent empowers biostatistics teams to deliver faster, cleaner, and more consistent outputs across the trial lifecycle. By automating TFL shell creation, interim analyses, and final reports, the agent eliminates repetitive formatting and QC tasks, reduces handoffs between teams, and accelerates time to insight. Built for scale, it brings greater efficiency and control to everything from DSMB packages to CSR-ready outputs - without disrupting your existing workflows.